PharmaShots Weekly Snapshot (April 22-26, 2019)
Published: April 26,2019 | Tags: Novo Nordisk, Files, MAA, Semaglutide, European Medicines Agency, EMA, Type 2 Diabetes
Published: April 25,2019 | Tags: Gilead, Reports, Results, Selonsertib, P-III, STELLAR 3, Study, Bridging Fibrosis, F3, NASH
3.Takeda Files NDA for Cabometyx (cabozantinib) to MHLW for Advanced Renal Cell Carcinoma in Japan
Published: April 25,2019 | Tags: Takeda, Files, NDA, Cabometyx, cabozantinib, MHLW, Advanced Renal Cell Carcinoma, Japan
Published: April 25,2019 | Tags: Merck, Reports, Updated, Results, Keytruda, pembrolizumab, P-III, KEYNOTE-062, Study, 1L, Treatment, Advance Gastric Cancer
Published: April 25,2019 | Tags: Salix (Bausch Health), Signs, License Agreement, Mitsubishi Tanabe Pharma, MT-1303, amiselimod, Inflammatory Bowel Disease, Ulcerative Colitis
6.B. Braun Launches its Heparin Sodium Prefilled Syringe in the US
Published: April 24,2019 | Tags: B. Braun, Launches, Ready-To-Use, Prefilled Syringe, Heparin Sodium Injection
Published: April 25,2019 | Tags: Eli Lilly, Facilitates, Withdrawal, Lartruvo, olaratumab, Global Market, Advanced Soft Tissue Sarcoma
8. ADC Therapeutics Signs a License Agreement with Adagene for its SAFEbody Technology
Published: April 24,2019 | Tags: ADC Therapeutics, Signs, License Agreement, Adagene, SAFEbody Technology
Published: April 24,2019 | Tags: Perelman School of Medicine, Signs, Research, Development, Agreement, Sensus Healthcare, Sculptura Intraoperative Radiation Therapy System
10.Takeda Signs a Licensing Option Agreement with Emendo Biotherapeutics for its OMNI Nuclease Program
Published: April 24,2019 | Tags: Takeda, Signs, Licensing Option Agreement, Emendo Biotherapeutics, OMNI Nuclease Program
Published: April 23,2019 | Tags: GSK, Signs, Exclusive, Worldwide, License, Agreement, Fulcrum Therapeutics, Develop, Commercialize, Losmapimod, Facioscapulohumeral Muscular Dystrophy
12. AbbVie's Skyrizi (risankizumab-rzaa) Receives FDA's Approval for Moderate to Severe Plaque Psoriasis
Published: April 23,2019 | Tags: AbbVie, Skyrizi (risankizumab-rzaa), Receives, FDA, Approval, Moderate, Severe, Plaque Psoriasis
13. OncoSec Initiates a Triple Combination Immunotherapy Trial for Squamous Cell Head and Neck Cancer
Published: April 23,2019 | Tags: OncoSec, Initiates, Triple Combination, Study, Immunotherapies, Squamous Cell Head and Neck Cancer
14.Teva Discontinues its P-III ENFORCE Study of Fremanezumab for Episodic Cluster Headache
Published: April 23,2019 | Tags: Teva, Discontinues, P-III, ENFORCE Study, Fremanezumab, Episodic Cluster Headache
15. BAROnova's TransPyloric Shuttle Device Receives FDA's Approval for the Treatment of Obesity in Adult
Published: April 23,2019 | Tags: BAROnova, TransPyloric Shuttle, Receive, FDA, Approval, Treatment, Obesity, Adults
16.NuVasive Reports Results of Cohere Porous PEEK Implants for Degenerative Cervical Disc
Published: April 22,2019 | Tags: NuVasive, Reports, Results, Cohere Porous PEEK Implants, Study, Patients, Degenerative Cervical Disc
17. Alder BioPharmaceuticals Reports FDA's Acceptance of BLA for Eptinezumab to Prevent Migraine
Published: April 22,2019 | Tags: Alder BioPharmaceuticals, Reports, FDA, Acceptance, BLA, Eptinezumab, Prevent, Migraine
Published: April 22,2019 | Tags: Eli Lilly, Sell, Chinese Rights, Antibiotics, Manufacturing Facility, Eddingpharm, $375M
19.Roche Launches Ventana HER2 Dual ISH CDx for the Identification of Breast and Gastric Cancer
Published: April 23,2019 | Tags: Roche, Launches, Ventana HER2 Dual ISH, CDx, Identification, Breast, Gastric Cancer
Published: April 22,2019 | Tags: Lilly, Reports, Results, Taltz, ixekizumab, P-III, COAST-X, Study, Non-Radiographic Axial Spondyloarthritis
Published: April 22,2019 | Tags: Merck, Keytruda, pembrolizumab, Inlyta, axitinib, Receive, FDA, Approval, 1L, Treatment, Advanced Renal Cell Carcinoma, RCC
Published: April 22,2019 | Tags: Lilly, Signs, Global, Research, Licensing, Agreement, Avidity Biosciences, Develop, New Therapies, Immunology
Published: April 18,2019 | Tags: TELA Bio, Restella Reconstructive BioScaffolds, Receives, FDA, 510(k), Clearance, Reconstructive Surgery
Published: April 19,2019 | Tags: Alvogen, Voluntary, Recalls, Two, Lots, Fentanyl Transdermal System, Product Mislabeling
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com